Jing Marantz
Chief Tech/Sci/R&D Officer bei SCHOLAR ROCK HOLDING CORPORATION
Vermögen: 1 Mio $ am 31.03.2024
Profil
Dr. Jing L. Marantz ist Senior Vice President-Medical Affairs bei Acceleron Pharma, Inc. Sie ist Mitglied des Board of Directors bei Krystal Biotech, Inc. Dr. Marantz war zuvor als Head-Medical Affairs & Senior Vice President bei Alnylam Pharmaceuticals, Inc. beschäftigt, als Vice President-Medical Affairs bei ARIAD Pharmaceuticals, Inc. und als Vice President-Global Medical Affairs bei Alexion Pharmaceuticals, Inc. Sie erhielt ihren MBA von der Haas School of Business, einen Doktortitel vom Tongji Medical College der Huazhong University of Sci & Tech und einen Doktortitel von der Medical University of South Carolina.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
12.02.2024 | 72 855 ( 0,09% ) | 1 Mio $ | 31.03.2024 | |
01.08.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Jing Marantz
Unternehmen | Position | Beginn |
---|---|---|
ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 07.12.2021 |
SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 09.11.2022 |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jing Marantz
Unternehmen | Position | Ende |
---|---|---|
KRYSTAL BIOTECH, INC. | Director/Board Member | 18.01.2022 |
ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 01.11.2021 |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2020 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.06.2018 |
ARIAD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Jing Marantz
Medical University of South Carolina | Doctorate Degree |
University of California, Berkeley | Masters Business Admin |
Tongji Medical College of Huazhong University of Sci & Tech | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
KRYSTAL BIOTECH, INC. | Health Technology |
SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |